共 23 条
[1]
Neil G., Haemolytic-uraemic syndrome in practice, Lancet, 343, (1994)
[2]
Beattie T.J., Recent developments in the pathogenesis of hemolytic uremic syndrome, Renal Failure, 12, (1990)
[3]
Kressel B.R., Ryan K.P., Duong A.T., Berenberg J., Schein P.S., Microangiopathic hemolytic anemia, thrombocytopenia, and renal failure in patients treated for adenocarcinoma, Cancer, 48, (1981)
[4]
Jackson A.M., Rose B.D., Graff L.G., Et al., Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy, Ann Intern Med, 101, (1984)
[5]
Murgo A.J., Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents, Semin Hematol, 24, (1987)
[6]
Gardner G., Mesler D., Gitelman H.I., Hemolytic uremic syndrome following cisplatin, bleomycin, and vincristine chemotherapy: A report of a case and a review of the literature, Renal Failure, 11, (1989)
[7]
Grem J.L., Merritt J.A., Carbone P.P., Treatment of mitomycin-associated microangiopathic hemolytic anemia with vincristine, Arch Intern Med, 146, (1986)
[8]
Dillman R.O., A new chemotherapeutic agent: deoxycoformycin (pentostatin), Semin Hematol, 31, (1994)
[9]
Spiers A.S.D., Moore D., Cassileth P.A., Et al., Remissions in hairy-cell leukemia with pentostatin (2′-deoxycoformycin), N Engl J Med, 316, (1987)
[10]
Dillman R.O., Yu A., Qiao C.N., Repeated pentostatin (2′-deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia, West J Med, 148, (1988)